Role of muscarinic receptor antagonists in urgency and nocturia (Q36219834)

12 August 2017

1 reference

title

Role of muscarinic receptor antagonists in urgency and nocturia (English)

1 reference

12 August 2017

1 reference

1

Martin C Michel

1 reference

12 August 2017

Jean J M C H de la Rosette

series ordinal

2

1 reference

12 August 2017

1 September 2005

1 reference

12 August 2017

1 reference

12 August 2017

96 Suppl 1

1 reference

12 August 2017

37-42

1 reference

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

The role of professional associations in reducing maternal mortality worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Does gender or age affect the efficacy and safety of tolterodine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Treatment satisfaction of patients with lower urinary tract symptoms: randomised controlled trials vs. real life practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Does concomitant stress incontinence alter the efficacy of tolterodine in patients with overactive bladder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

Clinical efficacy of tolterodine with or without a simplified pelvic floor exercise regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05651.X

10.1111/J.1464-410X.2005.05651.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16083453